News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rosiello Robert L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Rosiello Robert L. (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.11, valued at
$3.3k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/18/2022 |
4
| Rosiello Robert L. (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.99, valued at
$39.6k
|
|
| 10/17/2022 |
3
| Rosiello Robert L. (Director) has filed a Form 3 on Axcella Health Inc. |
| 12/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/08/2016 |
4
| Rosiello Robert L. (EVP, Corp Dev & Strategy) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 817 shares
@ $22.06, valued at
$18k
|
|
| 08/05/2016 |
4
| Rosiello Robert L. (EVP, CFO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 1,338 shares
@ $23.54, valued at
$31.5k
|
|
| 05/16/2016 |
4
| Rosiello Robert L. (EVP, CFO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 84,975 shares
@ $0 |
|
|
|